Redefining ‘success’: a systematic review and meta-analysis comparing outcomes between incomplete and complete revascularization

医学 荟萃分析 血运重建 内科学 外科 心肌梗塞
作者
Asim Rizvi,Seyed Mohammad Seyedsaadat,M. Hassan Murad,Waleed Brinjikji,Seán Fitzgerald,Ramanathan Kadirvel,Alejandro A. Rabinstein,David F. Kallmes
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:11 (1): 9-13 被引量:55
标识
DOI:10.1136/neurintsurg-2018-013950
摘要

Background Conventionally, ‘successful’ endovascular thrombectomy (EVT) had been defined as achieving revascularization of thrombolysis in cerebral infarction (TICI)−2B or greater, rather than as ‘complete’ (TICI-3) versus ‘incomplete’ (TICI-2B) revascularization. Purpose We performed a systematic review and meta-analysis of studies comparing clinical outcomes between patients with TICI-2B and TICI-3 revascularization. Methods Multiple databases were searched for relevant publications between January 2003 and March 2018. Studies comparing outcomes between the TICI-2B and the TICI-3 group of acute ischemic stroke (AIS) patients treated with EVT were included. Random effects meta-analysis was performed to evaluate outcomes among TICI-2B and TICI-3 groups. The following outcomes were assessed: good neurologic outcome (modified Rankin Scale (mRS)≤2 at day 90), mortality, and intracerebral hemorrhage (ICH). Results Twenty-one studies comprising 2747 patients were identified. Patients with TICI-2B revascularization had mRS≤2 at day 90 rates of 46% (391/847) compared with 66% (522/791) for TICI-3 patients (OR 0.46, 95% CI 0.37 to 0.57). Mortality rates were significantly higher in the TICI-2B group (78/570, 14%) than in the TICI-3 group (55/709, 8%) (OR 2.00, 95% CI 1.38 to 2.91). The ICH rates were also significantly higher in the TICI-2B group as compared with the TICI-3 group (31% [134/439] vs. 22% [108/490]; OR 2.20, 95% CI 1.47 to 3.30). Conclusions Differences in all major outcome measures were markedly better in patients with complete versus incomplete but still ‘successful’ revascularization using prior thresholds, with ORs in the order of those seen in recent definitive trials comparing EVT to an intravenous tissue plasminogen activator.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jk445完成签到,获得积分10
刚刚
合适的芸遥完成签到,获得积分10
刚刚
Kevin发布了新的文献求助10
1秒前
皮皮完成签到 ,获得积分10
1秒前
WW完成签到,获得积分10
1秒前
1秒前
hanger完成签到,获得积分10
1秒前
1秒前
研友_VZG7GZ应助成是非采纳,获得10
1秒前
共享精神应助jilgy采纳,获得10
2秒前
yangyang发布了新的文献求助20
3秒前
孝陵卫黑旋风完成签到,获得积分10
4秒前
强强强强完成签到,获得积分10
5秒前
情怀应助健达奇趣蛋采纳,获得10
6秒前
极品小亮发布了新的文献求助10
7秒前
7秒前
踟蹰完成签到,获得积分10
7秒前
8秒前
天天快乐应助好事连连采纳,获得10
8秒前
酷酷的芒果完成签到,获得积分20
8秒前
英俊的铭应助一白采纳,获得10
9秒前
9秒前
cz完成签到,获得积分20
9秒前
9秒前
徐新雨完成签到 ,获得积分10
11秒前
LIUJUN发布了新的文献求助10
12秒前
酷波er应助小狗采纳,获得10
12秒前
sxt完成签到,获得积分20
13秒前
14秒前
极品小亮完成签到,获得积分10
14秒前
不配.应助hcx采纳,获得10
16秒前
17秒前
Lucas发布了新的文献求助10
19秒前
俏皮丹妗完成签到,获得积分20
19秒前
hanger发布了新的文献求助30
19秒前
轩海完成签到 ,获得积分10
20秒前
hy_发布了新的文献求助10
20秒前
21秒前
21秒前
21秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3135127
求助须知:如何正确求助?哪些是违规求助? 2786103
关于积分的说明 7775305
捐赠科研通 2441924
什么是DOI,文献DOI怎么找? 1298299
科研通“疑难数据库(出版商)”最低求助积分说明 625112
版权声明 600839